Where investigated, studies have demonstrated positive risks of similar strength for neopterin17–19 and C-reactive protein (CRP)17, an established non-specific marker of systemic inflammation25, with cardiovascular disease. This evidence concerns the gene CRP and cardiovascular disorder.